162 related articles for article (PubMed ID: 15586810)
1. [Synthesis and antiaggregative activity of a new RGDF mimetic].
Krys'ko AA; Malovichko OL; Kabanova TA; Mazepa AV
Bioorg Khim; 2004; 30(6):594-8. PubMed ID: 15586810
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiaggregatory activity of RGD-peptidomimetics based on 4-oxo-4-(piperazine-1-yl)butyric acid as Arg-mimetic.
Andronati SA; Krysko AA; Kabanov VM; Kabanova TA; Karaseva TL; Chugunov BM; Meshkova SB; Topilova ZM
Acta Pol Pharm; 2003; 60(5):375-81. PubMed ID: 15005421
[TBL] [Abstract][Full Text] [Related]
3. Novel fibrinogen receptor antagonists. RGDF mimetics, derivatives of 4-(isoindoline-5-yl)amino-4-oxobutyric acid.
Krysko AA; Chugunov BM; Malovichko OL; Andronati SA; Kabanova TA; Karaseva TL; Kiriyak AV
Bioorg Med Chem Lett; 2004 Nov; 14(22):5533-5. PubMed ID: 15482918
[TBL] [Abstract][Full Text] [Related]
4. Circular dichroism studies of type III collagen mimetic peptides with anti- or pro-aggregant activities on human platelets.
Pêcher J; Pires V; Djaafri I; Da Nascimento S; Fauvel-Lafève F; Legrand C; Sonnet P
Eur J Med Chem; 2009 Jun; 44(6):2643-50. PubMed ID: 19056149
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular docking studies of 2-piperazin-1-yl-quinazolines as platelet aggregation inhibitors and ligands of integrin αIIbβ3.
Krysko AA; Kornylov AY; Polishchuk PG; Samoylenko GV; Krysko OL; Kabanova TA; Kravtsov VCh; Kabanov VM; Wicher B; Andronati SA
Bioorg Med Chem Lett; 2016 Apr; 26(7):1839-43. PubMed ID: 26912112
[TBL] [Abstract][Full Text] [Related]
6. A shortcut to peptides to modulate platelets.
Apic G; Russell RB
Nat Chem Biol; 2007 Feb; 3(2):83-4. PubMed ID: 17235341
[No Abstract] [Full Text] [Related]
7. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
[TBL] [Abstract][Full Text] [Related]
8. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs].
Mel'nik OV; Martinovich VP; Golubovich VP
Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
10. [The synthesis of arginine derivatives of chromone and azauracil].
Poiarkov AA; Frasiniuk MS; Kibirev VK; Poiarkova SA
Bioorg Khim; 2006; 32(3):308-10. PubMed ID: 16808173
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents.
Higuchi K; Hikita H; Murayama A; Yuri D; Kobayakawa N; Takahashi T; Kojima S; Ueno H; Hatakeyama T; Kato A; Tayu M; Oyama E; Sugiyama S; Ishii K; Takahashi H; Kawasaki T
Chem Pharm Bull (Tokyo); 2016; 64(12):1726-1738. PubMed ID: 27904082
[TBL] [Abstract][Full Text] [Related]
12. New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological target.
Biagi G; Giorgi I; Livi O; Scartoni V; Catalani R; Gervasi G
Farmaco; 1996 Dec; 51(12):761-6. PubMed ID: 9050207
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors.
Cristalli G; Podda GM; Costanzi S; Lambertucci C; Lecchi A; Vittori S; Volpini R; Zighetti ML; Cattaneo M
J Med Chem; 2005 Apr; 48(8):2763-6. PubMed ID: 15828813
[TBL] [Abstract][Full Text] [Related]
14. Novel synthetic approach to N-aryl-4-(3-pyridyl)thiazol-2-amine and analogues using HMCM-41 as catalyst, and their biological evaluation as human platelet aggregation inhibitors.
Bhoga U
Eur J Med Chem; 2007 Aug; 42(8):1144-50. PubMed ID: 17350143
[TBL] [Abstract][Full Text] [Related]
15. [Antiaggregation activity of arachidonic acid conjugates with neurotropic peptides proglyprol and semax].
Bezuglov VV; Gretskaia NM; Vasil'eva TM; Petrukhina GN; Andreeva LA; Miasoedov NF; Makarov VA
Eksp Klin Farmakol; 2014; 77(6):30-2. PubMed ID: 25102733
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic discovery of novel bioactive peptides.
Edwards RJ; Moran N; Devocelle M; Kiernan A; Meade G; Signac W; Foy M; Park SD; Dunne E; Kenny D; Shields DC
Nat Chem Biol; 2007 Feb; 3(2):108-12. PubMed ID: 17220901
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis of lipophilic RGD-peptide derivatives].
Stepanenko EG; Sebiakin IuL
Bioorg Khim; 2004; 30(2):126-9. PubMed ID: 15143666
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-diones.
Dal Piaz V; Ciciani G; Giovannoni MP
Drug Des Discov; 1996 Mar; 14(1):53-75. PubMed ID: 8854045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
